the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients

Completed

• Conditions: Venous Thromboembolism
• Interventions: Other: risk evolution scale

• Registration Number: NCT04963374
• Lead Sponsor: Peking University Third Hospital

Brief Summary

To compare the predictive effectiveness of the Caprini risk assessment model, the Padua risk assessment model and the VTE risk assessment in medical patients mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism on the risk of concomitant VTE in respiratory inpatients to provide a basis for clinical VTE assessment and treatment.

Detailed Description

A case-control study was used to collect patients who developed VTE during hospitalization in the Department of Respiratory Medicine at Peking University Third Hospital Hospital from January 2015 to December 2020 as the case group, and 2-fold patients who did not develop VTE matched to the case group (age, sex, ADL score, diagnosis, and length of hospitalization) as the control group. The general status of the patients was also assessed using the Padua risk model, the Caprini risk model, and the VTE risk assessment scale for medical patients mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment, and prevention of pulmonary thromboembolism, and the relevant items involved in the assessment form were obtained by reviewing the cases.

Study Timeline

• Study Start: 2021-04-01
• Study First Submitted: 2021-06-29
• Study First Submitted QC: 2021-07-08
• Study First Posted: 2021-07-15
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-20
• Last Update Posted: 2023-11-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• age more than 18y respiratory inpatient

Read More

Exclusion Criteria

• Patients with deep vein thrombosis or pulmonary thromboembolism, sequelae of deep vein thrombosis, and thrombosis in other parts of lower limbs were diagnosed; Patients with severe coagulation dysfunction or other hematological diseases

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
respiratory inpatient	risk evolution scale	respiratory inpatient with VTE

Primary Outcome Measures

Name	Time	Method
VTE incidence	during hospitalization， an average of 2 weeks	VTE incidence in patients with high risk of VTE

Trial Locations

Locations (1)

Peking UTH; 🇨🇳 Beijing, Beijing, China